ProfileGDS4459 / ENSG00000146216
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 68% 55% 42% 68% 47% 47% 48% 46% 40% 44% 49% 42% 46% 47% 48% 54% 39% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.1468
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.5855
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.0342
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.1768
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.2747
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.2947
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.3448
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.1846
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.9840
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.2144
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.2749
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.0342
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.2646
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.3247
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.2748
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.5454
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.0239